Asker Healthcare Group AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	17,313	16,787	15,025	13,453	11,718	9,354
Revenue Growth (YoY)	11.23%	11.73%	11.68%	14.81%	25.27%	-
Cost of Revenue	10,206	9,916	9,147	8,934	7,936	6,741
Gross Profit	7,107	6,871	5,878	4,519	3,782	2,613
Selling, General & Admin	5,987	5,799	4,851	3,886	2,674	1,778
Amortization of Goodwill & Intangibles	-	-	-	-	167	68
Other Operating Expenses	-46	-21	-15	-7	-	-
Operating Expenses	5,941	5,778	4,836	3,879	3,069	2,008
Operating Income	1,166	1,093	1,042	640	713	605
Interest Expense	-88	-211	-302	-264	-186	-23
Interest & Investment Income	10	10	9	3	1	1
Currency Exchange Gain (Loss)	-5	-5	-1	24	93	-27
Other Non Operating Income (Expenses)	-130	-57	-73	-34	-60	-12
EBT Excluding Unusual Items	953	830	675	369	561	544
Gain (Loss) on Sale of Assets	-	-	32	-	-	-
Other Unusual Items	-171	-171	-149	-61	-	-
Pretax Income	782	659	558	308	561	544
Income Tax Expense	170	149	183	103	127	74
Earnings From Continuing Operations	612	510	375	205	434	470
Minority Interest in Earnings	-18	-18	-15	-2	-4	-3
Net Income	594	492	360	203	430	467
Net Income to Common	594	492	360	203	430	467
Net Income Growth	54.69%	36.67%	77.34%	-52.79%	-7.92%	-
Shares Outstanding (Basic)	345	368	321	262	258	236
Shares Outstanding (Diluted)	345	368	321	262	258	236
Shares Change (YoY)	-4.37%	14.59%	22.56%	1.55%	9.55%	-
EPS (Basic)	1.72	1.34	1.12	0.77	1.67	1.98
EPS (Diluted)	1.72	1.34	1.12	0.77	1.67	1.98
EPS Growth	50.39%	19.27%	44.70%	-53.51%	-15.95%	-
Free Cash Flow	1,019	738	879	901	853	258
Free Cash Flow Per Share	2.95	2.00	2.73	3.44	3.30	1.09
Dividend Per Share	0.390	0.390	-	-	-	-
Gross Margin	41.05%	40.93%	39.12%	33.59%	32.27%	27.93%
Operating Margin	6.73%	6.51%	6.93%	4.76%	6.08%	6.47%
Profit Margin	3.43%	2.93%	2.40%	1.51%	3.67%	4.99%
Free Cash Flow Margin	5.89%	4.40%	5.85%	6.70%	7.28%	2.76%
EBITDA	1,579	1,560	1,351	933	896	670
EBITDA Margin	9.12%	9.29%	8.99%	6.93%	7.65%	7.16%
D&A For EBITDA	412.75	467	309	293	183	65
EBIT	1,166	1,093	1,042	640	713	605
EBIT Margin	6.73%	6.51%	6.93%	4.76%	6.08%	6.47%
Effective Tax Rate	21.74%	22.61%	32.80%	33.44%	22.64%	13.60%
Revenue as Reported	-	-	-	-	11,751	9,378

Source: S&P Global Market Intelligence. Standard template. Financial Sources.